|
Volumn 25, Issue 9, 2007, Pages 1143-1144
|
Docetaxel as monotherapy in the treatment of advanced non-small-cell lung cancer in elderly patients [5]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOCETAXEL;
GEFITINIB;
NAVELBINE;
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
TAXOID;
VINBLASTINE;
ADVANCED CANCER;
AGED;
CANCER STAGING;
CANCER SURVIVAL;
COMORBIDITY;
FLUID RETENTION;
HUMAN;
LETTER;
LUNG NON SMALL CELL CANCER;
MONOTHERAPY;
NAIL DISEASE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SIDE EFFECT;
TREATMENT RESPONSE;
AGE;
DISEASE FREE SURVIVAL;
LUNG TUMOR;
NOTE;
PATHOLOGY;
PATIENT SELECTION;
TREATMENT OUTCOME;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARCINOMA, NON-SMALL-CELL LUNG;
DISEASE-FREE SURVIVAL;
HUMANS;
LUNG NEOPLASMS;
NEOPLASM STAGING;
PATIENT SELECTION;
TAXOIDS;
TREATMENT OUTCOME;
VINBLASTINE;
|
EID: 34047222542
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2006.09.0043 Document Type: Letter |
Times cited : (3)
|
References (3)
|